In a chilling “first” for medical literature, Australian scientists have documented an unprecedented case of a right ventricular thrombus — a dangerous blood clot inside the heart’s right chamber — in a 16-year-old boy three days after his third dose of Pfizer’s mRNA COVID-19 vaccine.
The peer-reviewed case study, published in Heart, Lung and Circulation and authored by M. Bakry, W. Liu, and B. Lambert, marks the first time such a clot has been recorded anywhere in the world in connection with post-vaccine heart inflammation.
According to the study, the teen developed myo-pericarditis — inflammation of the heart muscle and surrounding sac — just three days after receiving his Pfizer booster shot.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
You can unsubscribe any time. By subscribing you agree to our Terms of Use
His initial treatment included colchicine for three months and ibuprofen for two weeks, and for a while, the worst seemed behind him.
Edward Snowden Exposes Erika Kirk As "Sleeper CIA Agent" Who Murdered Charlie on Command
But five months later, he was back in hospital with chest pain — and doctors were stunned to discover a 15×11 mm mobile mass lodged in his right ventricular outflow tract, an extremely rare and never-before-recorded type of heart clot that had been completely absent in earlier scans.
The medical team performed open-heart surgery to remove it, confirming it was a non-infective thrombus. Fortunately, the boy survived and was discharged on daily aspirin therapy.
A Red Flag in a Growing Pattern
While public health authorities still describe vaccine-induced myo-pericarditis as “rare,” post-vaccine cardiac events have surged since the mass rollout of mRNA shots, particularly among younger males.
Reports of myocarditis, pericarditis, arrhythmias, and even sudden cardiac deaths in the weeks and months following vaccination have raised urgent questions about the long-term safety of these novel injections — questions that critics argue are being downplayed or dismissed entirely by mainstream health agencies.
RELATED: Cleveland Clinic Warns 50% of Covid Vaccine Myocarditis Cases Will Be Dead Within 5 Years
The Australian team warns that this case underlines the need for “vigilance” and “continued follow-up” for patients who experience vaccine-induced heart inflammation, especially those with prior cardiac surgery.
They also note that the exact mechanism behind the clot remains unclear, though it may involve a pro-inflammatory response or molecular mimicry triggered by the vaccine — the same immune mechanisms suspected in other post-vaccine complications.
Why This Matters
The fact that this is the first recorded case worldwide of a right ventricular thrombus following vaccine-induced myo-pericarditis should be a wake-up call.
As the authors themselves admit, the current medical guidelines do not recommend routine blood-thinning therapy in such patients — meaning similar cases could go undetected until it’s too late.
In light of this unprecedented event and the growing body of data on post-vaccine cardiac issues, many are asking whether the medical establishment has underestimated the scope of the risks. And more urgently: how many more “firsts” will it take before the warnings are heeded?
